1/110
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Type 1 Immune reaction
IgE (soluble antigen)
Type 1 Allergy
Immediate hypersensitivity (5 to 30 mins)
Effector mechanism of Type 1 allergies
mast cell activation
clinical manifestation of typle 1 allergies
allergic rhinitis
asthma
anaplylaxis
Type 2 immune reaction
IgG/IgM (associated antigen)
Type 2 allergy
antibody-mediated cytotoxic hypersensitivity (minutes to hours)
Effector mechanism of Type 2
complement mediated phagocytosis
clinical manifestation of type 2
-drug allergy
-graves disease
-anemia
type 3 immune reaction
IgG/IgM (soluble antigen)
Type 3 allergy
immune complex mediated hypersensitivity (3-8 hours)
Type 3 effector mechanism
tissue damage induced by immune complexes
clinical manifestation of type 3 allergies
-rheumatoid arthritis
-serum sickness
-SLE
Type 4 immune reaction
T cells (soluble or cell bound antigen)
Type 4 allergy
cell-mediated hypersensitivity (48-72 hours)
Type 4 effector mechanism
T cell medicated inflammation or cytotoxicity
Type 4 clinical manifestation
-contact dermatitis
-graft rejection
-chronic asthma
type 1 and 4
What are the most common types of allergies?
Type 1
What is the worst type of allergy?
10%
What % of patients report a penicillin allergy?
0.2-0.4%
What % of penicillin allergies are anaphylaxis?
0.7-1%
What % of penicillin allergies have hypersensitivity reactions?
0.004-0.04%
What % of allergies have anaphylactoid reactions?
10%
Cephalosporins have ____ cross reactivity with penicillin allergies.
1%
Carbapenems have a less than ___ cross reactivity with penicillin allergies.
3-8%
What % of the pop has sulfa allergies?
rash
What is the most common manifestation of Sulfa Allergies?
Type 1 Sulfa allergy
•anaphylactoid reaction: ONLY N1 substituent
-NO non-antibiotics with a S contain and N1 substituent
Type 2/3 sulf allergies
•antibody formation
-Antibodies do NOT cross-react to ANYTHING but sulfonamide antibiotics
Type 4 sulfa allergies
•at N4: nitroso metabolite
•Increased incidence of allergy with penicillin than non-antibiotic containing sulfonamides (multiple drug allergies)
Cephalexin
Which antimicrobial is MOST likely to cross-react with amoxicillin?
A.Cefepime
B.Ceftriaxone
C.Cephalexin
D. Sulfamethoxazole
Cefoxitin
What drug cross reacts with Penicillin?
Ampicillin and Cephalexin
What drugs cross reacts with Amoxicillin?
Amoxicillin and Cephalexin
What drugs cross react with Ampicillin?
Amoxicillin and Ampicillin
What drugs cross react with Cephalexin?
Cefoxitin, Ceftriaxone, Cefotaxime
What drugs cross react with Cefuroxime?
Penicillin and Cefuroxime
What drugs cross react with Cefoxitin?
Cefuroxime, Cefotaxime, Cefepime, Ceftazidime
What drugs cross react with Ceftriaxone?
Cefuroxime, Ceftriaxone, Ceftazidime
What drugs cross react with Cefotaxime?
Ceftriaxone
What drug cross reacts with Cefepime?
Ceftriaxone and Cefotaxime
What drug cross reacts with Ceftazidime?
-Optimal vs. permissible therapy
-ADEs
-Outcomes
Why should you clarify allergies?
•What allergies do you have? (all allergies should be noted)
•What happened when you took this/these medications?
•How did you take the medication? (note route)
•When did you have these reactions? (in your lifetime)
•When did you have the reaction, relative to the first dose?
•How many doses did you have before seeing the reaction?
•Were you taking any other medications at the same time?
•Were you exposed to other allergens at the same time?
•How did you manage the reaction? (self-care versus seek help)
•What happened when you stopped taking the medication?
•Have you taken that medication again since then? Did you tolerate it?
•Have you taken any similar medications since then? Did you tolerate it/them?
What questions should you ask when assessing an antimicrobial allergy?
Category A FDA Pregnancy Category
adequate and well controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters)
Category B FDA Pregnancy Category
Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well controlled studies in pregnant women
Category C FDA pregnancy category
Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well controlled studies in humans but potential benefits may warrant use of the drug in pregnant women despite potential risks
Category D FDA pregnancy category
there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks
category X FDA pregnancy category
studies in animals or humans have demonstrated fetal abnormalities and or there is pos evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits
provides information and data but not categories and is required for all new agents, new indications and new package inserts
includes:
pregnancy (labor and delivery)
lactation (nursing mothers)
females and males of reproductive potential
The classification system of pregnancy regulation updates:
-Penicillins
-Cephalosporins
-Carbapenems
-Vancomycin
-Clindamycin
-Daptomycin
-Fidaxomicin
-Metronidazole
What are the safe antimicrobials in pregnancy?
-Aminoglycosides
-Fluoroquinolones
-Tetracyclines
-Clarithromycin
-Lipoglycopeptides
What are the antimicrobials that we have concerns with use?
Aminoglycoside concerns with pregnancy
-Hearing loss, particularly in first trimester
-Particularly with streptomycin
-Others okay for short-term use
Fluoroquinolone concerns with pregnancy
-Animal studies: renal toxicity, cardiac defects, CNS toxicity, bone and cartilage damage
-Avoid use unless benefit outweighs risks
Macrolides: Clarithromycin concerns with pregnancies
-Cardiac abnormalities, particularly in first trimester
-Use clarithromycin/erythromycin with caution and only if benefit outweighs risks
-Azithromycin is generally safe
Tetracyclines concerns with pregnancy
-Congenital defects, discoloration of bones and teeth
-Avoid in pregnancy
Lipoglycopeptides concerns with pregnancy
-Limb and skeletal malformations and fetal weight loss
-Particularly with televancin
-Avoid unless benefit outweighs risks
Oxazolidinones concerns with pregnancy
-Decreased fetal body weight
-May use if benefit outweighs risks
Bactrim concerns with pregnancy
-1st trimester: Major congenital malformations
-After 32 weeks: kernicterus
-Avoid in first trimester and after 32 weeks gestation
-Acyclovir
-Valacyclovir
-Famciclovir
What are the antivirals that are generally safe in pregnancy?
-Cidofovir
-Ganciclovir
-Foscarnet
-Amantadine & Rimantadine
What drugs do we have concerns with use in pregnancy?
Cidofovir specific concerns with pregnancy
-Soft tissue and skeletal abnormalities
-Avoid unless benefits outweigh risks
Ganciclovir specific concerns with pregnancy
-Embryo death, growth retardation, cleft palate, aplastic organs, hydrocephaly
-Use with caution and only if benefits outweigh risks
Foscarnet specific concerns with pregnancy
-Skeletal abnormalities (bone and teeth growth)
-Use with caution
Amantadine and Rimantadine specific concerns with pregnancy
-Embryotoxic at high doses, birth defects in first trimester
-Only use if benefits outweigh risks
Neuraminidase inhibitors special concerns
-Hypoglycemia after birth
-Seen with oseltamivir, but likely is acceptable to use
Amphotericin
What antifungal is generally safe in pregnancy?
Azole and Flucytosine
What antifungals are concerns in pregnancy?
Fluconazole specific concerns in pregnancy
-Skeletal, cranial, and functional abnormalities, spontaneous abortion,
-Pregnancy category D (Avoid) except for vaginal candidiasis (C)
-Contraindicated at doses higher than 300 mg
-Avoid even low doses in first trimester
Itraconazole specific concerns with pregnancy
-Spontaneous abortion
-Avoid, especially in first trimester
-Use contraception for 2 months following use
Voriconazole specific conerns in pregnancy
-Reduced fetal weight, skeletal abnormalities
-Lack of human data, so contraindicated in pregnancy unless benefits outweigh risks
Posaconazole specific concerns with pregnancy
-Skeletal malformations (cranial malformations, missing ribs)
-Avoid use in pregnancy
-Use contraception for 2 months following use
Isavuconazole specific concerns with pregnancy
-Increase in perinatal mortality
-Use only in life-threatening situations when benefits outweigh risks
Echinocandins specific concerns with pregnancy
-Embryotoxic in rats and rabbits (ossification of bones, misaligned ribs, retrocaval ureters, dilation of ureter)
-Use only when benefits outweigh risks
Flucytosine specific concerns in pregnancy
-Teratogenic in rats (vertebral fusions, cleft lip and palate, micrognathia)
-Contraindicated, use only if benefits outweigh risks
Piperacillin/Tazobactam
Which antimicrobial would be SAFEST/MOST APPROPRIATE for use in a pregnant patient?
A. Posaconazole
B. Ganciclovir
C. Sulfamethoxazole/trimethoprim
D. Piperacillin/Tazobactam
-plasma protein binding
-lipophilicity
-size impact
What impacts whether the antimicrobial is transferred to breast milk?
decreases; increases
-Higher plasma protein binding ___________ transfer, but higher milk protein binding ___________ transfer.
high
_______ lipophilicity increases milk transfer.
decreases
High molecular weight _______ transfer.
lactation
amount is usually reported as milk to plasma ratio
Metronidazole specific concerns with lactation
discontinue BF for 12-24 hours
Tetracyclines specific concerns with lactation
should not be excreted in huge concentrations but risk of issues with tooth development
-lipoglycopeptides
-oxazolidinones
-polymyxins
What antimicrobials have limited lactation information?
antifungals specific concerns with lactation
-limited information for all antifungals
fluconazole
What is the azole of choice for breastfeeding?
famciclovir specific concerns for lactation
it has limited information
Fluoroquinolone with pediatric use
•Not routinely first-line
•Weight benefits and risks
•Levofloxacin: PI says >50 kg and > 6 months
•Moxifloxacin: PI says no information, drug information resources provide guidelines for > 3 months (anthrax,TB)
Tetracyclines in pediatrics
Use in < 8 years reserved for severe, life-threatening infections or where better alternatives are unavailable
Daptomycin use in pediatrics
Avoid use < 12 months
Chloramphenicol use in pediatrics
Follow serum concentrations, only use when less toxic agents are unavailable or resistant
Posaconazole use in peds
PI provides dosing ≥ 18 years
Baloxavir use in peds
Approved in children >12 years
Zanamivir use in peds
Approved in children > 7 years
hepatic elimination physiologic alterations
fatty infiltration may decrease CYP 3A4 isoforms, increase phase II reactions/metabolism
renal elimination physiologic alterations
some indication that obesity may increase glomerular filtration (increased number or size of nephrons)
volume of distribution physiologic alterations
•no correlative with body weight
-Hydrophilic drugs correlate to lean body mass
-Lipophilic drugs correlate to total body weight
total body weight
assumes everything increases proportionally with weight; overestimates CrCl
ideal body weight
doesnt account for body types
lean body weight
also called adjusted body weight
body mass index
doesnt distinguish fat/muscle/bone
body surface area
non-linear, disproportionate increase in surface area for given increase in total body weight